These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 8078414
41. Active site of staphylococcal beta-lactamase. Cartwright SJ, Coulson AF. Philos Trans R Soc Lond B Biol Sci; 1980 May 16; 289(1036):370-2. PubMed ID: 6109335 [No Abstract] [Full Text] [Related]
42. Gly-238-Ser substitution changes the substrate specificity of the SHV class A beta-lactamases. Lee KY, Hopkins JD, O'Brien TF, Syvanen M. Proteins; 1991 May 16; 11(1):45-51. PubMed ID: 1961701 [Abstract] [Full Text] [Related]
43. [Beta-lactamase inhibitors. II. Synthesis and biological properties of 6-sulfonylaminopenicillanic acids]. Kazimierczak J, Mikołajczyk J, Kotulowa W, Cieślak J. Acta Pol Pharm; 1984 May 16; 41(6):619-23. PubMed ID: 6100225 [No Abstract] [Full Text] [Related]
44. Kinetic characterization of a slow-binding inhibitor of Bla2: thiomaltol. Schlesinger SR, Bruner B, Farmer PJ, Kim SK. J Enzyme Inhib Med Chem; 2013 Feb 16; 28(1):137-42. PubMed ID: 22233540 [Abstract] [Full Text] [Related]
45. [Enzyme determination in vitro of inhibitor activity of beta-lactamase from tazobactam. Comparison with high performance liquid chromatography]. Sotto A, Brunschwig C, Ramuz M, Jourdan J. Pathol Biol (Paris); 1997 Jan 16; 45(1):77-81. PubMed ID: 9097851 [Abstract] [Full Text] [Related]
46. Pre-steady state beta-lactamase kinetics. Observation of a covalent intermediate during turnover of a fluorescent cephalosporin by the beta-lactamase of STaphylococcus aureus PC1. Anderson EG, Pratt RF. J Biol Chem; 1981 Nov 25; 256(22):11401-4. PubMed ID: 6975275 [Abstract] [Full Text] [Related]
47. CENTA as a chromogenic substrate for studying beta-lactamases. Bebrone C, Moali C, Mahy F, Rival S, Docquier JD, Rossolini GM, Fastrez J, Pratt RF, Frère JM, Galleni M. Antimicrob Agents Chemother; 2001 Jun 25; 45(6):1868-71. PubMed ID: 11353639 [Abstract] [Full Text] [Related]
48. Why tazobactam and sulbactam have different intermediates population with SHV-1 β-lactamase: a molecular dynamics study. Li R, Wang YT, Chen CL. J Mol Model; 2013 Jun 25; 19(6):2519-24. PubMed ID: 23455927 [Abstract] [Full Text] [Related]
50. 6-(hydroxyalkyl)penicillanates as probes for mechanisms of beta-lactamases. Golemi D, Maveyraud L, Ishiwata A, Tranier S, Miyashita K, Nagase T, Massova I, Mourey L, Samama JP, Mobashery S. J Antibiot (Tokyo); 2000 Oct 25; 53(10):1022-7. PubMed ID: 11132946 [Abstract] [Full Text] [Related]
51. Crystal structures of the molecular class A β-lactamase TEM-171 and its complexes with tazobactam. Grigorenko VG, Petrova TE, Carolan C, Rubtsova MY, Uporov IV, Pereira J, Chojnowski G, Samygina VR, Lamzin VS, Egorov AM. Acta Crystallogr D Struct Biol; 2022 Jul 01; 78(Pt 7):825-834. PubMed ID: 35775982 [Abstract] [Full Text] [Related]
52. Quantitative analysis of the stabilization by substrate of Staphylococcus aureus PC1 beta-lactamase. Lejeune A, Vanhove M, Lamotte-Brasseur J, Pain RH, Frère JM, Matagne A. Chem Biol; 2001 Aug 01; 8(8):831-42. PubMed ID: 11514231 [Abstract] [Full Text] [Related]
53. Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 A resolution. Herzberg O, Moult J. Science; 1987 May 08; 236(4802):694-701. PubMed ID: 3107125 [Abstract] [Full Text] [Related]
54. Comparative stabilities of penicillins and cephalosporins to staphylococcal beta-lactamase and activities against Staphylococcus aureus. Selwyn S. J Antimicrob Chemother; 1980 Nov 08; 6(6):794-5. PubMed ID: 6969252 [No Abstract] [Full Text] [Related]
55. A comparative study of class-D beta-lactamases. Ledent P, Raquet X, Joris B, Van Beeumen J, Frère JM. Biochem J; 1993 Jun 01; 292 ( Pt 2)(Pt 2):555-62. PubMed ID: 8389139 [Abstract] [Full Text] [Related]
56. Cryoenzymology of staphylococcal beta-lactamase: trapping a serine-70-linked acyl-enzyme. Virden R, Tan AK, Fink AL. Biochemistry; 1990 Jan 09; 29(1):145-53. PubMed ID: 2108714 [Abstract] [Full Text] [Related]
57. Mechanism of inhibition of the PC1 beta-lactamase of Staphylococcus aureus by cephalosporins: importance of the 3'-leaving group. Faraci WS, Pratt RF. Biochemistry; 1985 Feb 12; 24(4):903-10. PubMed ID: 3873255 [Abstract] [Full Text] [Related]
58. Identification of a β-lactamase inhibitory protein variant that is a potent inhibitor of Staphylococcus PC1 β-lactamase. Yuan J, Chow DC, Huang W, Palzkill T. J Mol Biol; 2011 Mar 11; 406(5):730-44. PubMed ID: 21238457 [Abstract] [Full Text] [Related]
59. Evidence of human serum albumin beta-lactamase activity. Nerli B, Picó G. Biochem Mol Biol Int; 1994 Mar 11; 32(4):789-95. PubMed ID: 8038728 [Abstract] [Full Text] [Related]
60. Isolation of a Staphylococcus aureus beta-lactamase-dicloxacillin complex and kinetic studies on the reactivation of the enzyme. Hardy LW, Kirsch JF. Arch Biochem Biophys; 1989 Jan 11; 268(1):338-48. PubMed ID: 2783544 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]